United Kingdom

People: VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

13 Dec 2018
Change (% chg)

$-0.07 (-4.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Dotson, Jerrold 

Mr. Jerrold D. Dotson, CPA, is the Chief Financial Officer, Vice President, Company Secretary of Vistagen Therapeutics, Inc. He has served as our Chief Financial Officer since September 2011, as our Corporate Secretary since October 2013 and as a Vice President since February 2014. Mr. Dotson served as Corporate Controller for Discovery Foods Company, a privately held Asian frozen foods company from January 2009 to September 2011. From February 2007 through September 2008, Mr. Dotson served as Vice President, Finance and Administration (principal financial and accounting officer) for Calypte Biomedical Corporation (OTCBB: CBMC), a publicly held biotechnology company. Mr. Dotson served as Calypte’s Corporate Secretary from 2001 through September 2008. He also served as Calypte’s Director of Finance from January 2000 through July 2005 and was a financial consultant to Calypte from August 2005 through January 2007. Prior to joining Calypte, from 1988 through 1999, Mr. Dotson worked in various financial management positions, including Chief Financial Officer, for California & Hawaiian Sugar Company, a privately held company. Mr. Dotson is licensed as a CPA in California and received his BS degree in Business Administration with a concentration in accounting from Abilene Christian College.

Basic Compensation

Total Annual Compensation, USD 250,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 229,350
Fiscal Year Total, USD 479,350

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

H. Snodgrass


Shawn Singh


Jerrold Dotson


Mark Smith


Jerry Gin


Jon Saxe

As Of  31 Mar 2015